We say farewell to Jorge Combarros today. Jorge has been on a 2-month secondment from Gadea Grupo Farmacéutico in Valladolid (part of AmriGlobal). His project is part of a larger EU collaboration, 3DNet, led by Dr Breandán Kennedy (UCD School of Biomolecular & Biomedical Science). While in Dublin he has worked on the synthesis of new molecules that will be tested as therapeutics for diseases of the eye. Jorge has done great work in this regard. In addition he has taught us a lot about working in industry, and about the techniques he has experise in. This ‘transfer-of-knowledge’ is a key goal of the FP7- Marie Curie IAPP grant that funded the secondment. We wish Jorge all the best for his future.
Avene Colgan has gone to Spain on Industrial Placement for 3 months. As part of our ongoing participation in the 3DNet EU project, Avene is now on a 3-month secondment with Gadea Grupo Farmacéutico in Valladolid, Spain. The project is funded by a FP7-Marie Curie IAPP grant and is led by Dr Breandán Kennedy in UCD. Avene is pausing her PhD studies (funded by the IRC) in order to gain valuable industrial experience. While in Spain she will be working on the synthesis of novel molecules that will be tested for their potential as therapeutics for eye diseases. We wish her all the best on her travels.